The fact that TEVA has decided to hire a former senior level FDA Scientist as their US regulatory affairs VP suggests that they are unhappy with the progress on their reviews at the FDA. I believe that this may be a signal that they feel the need for more regulatory liaison capabilities in the US. This may be a direct outgrowth of their Lovenox ANDA being stuck in the mud for so long.